Literature DB >> 1746528

New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.

J C Anthony1, D Vlahov, K E Nelson, S Cohn, J Astemborski, L Solomon.   

Abstract

To examine whether recent intravenous use of cocaine might be associated with increased risk of human immunodeficiency virus type 1 (HIV) infection, the authors studied 2,597 active intravenous drug users: 2,399 with recent cocaine injection and 198 with recent injection of heroin or other drugs but not cocaine. These subjects were adult residents of Baltimore City and the surrounding Maryland counties, recruited via outreach into the community between February 1988 and March 1989. In contrast to the first report on the cocaine-HIV association, the present study sample was not recruited solely from drug treatment programs. In the present study, estimated HIV seroprevalence was 26.4% for recent cocaine injectors as compared with 10.6% among all other recent intravenous drug users; the relative odds estimate was 3.03. In the untreated segment of the sample, HIV seroprevalence was 26.0% for recent cocaine injectors as compared with 8.9% among others (relative odds (RO) = 3.61). The estimated degree of association did not change appreciably when multiple logistic regression was used to hold constant potentially confounding and/or mediating variables such as receptive anal intercourse, number of sex partners, and use of injection equipment obtained at shooting galleries (RO = 2.64). Augmenting these cross-sectional data, preliminary prospective data showed excess risk of HIV seroconversion among recent cocaine injectors (estimated relative risk = 2.11). While other research has examined the cocaine-HIV association, the present study differs in that it has allowed a test for whether the association was a spurious artifact of studying drug users recruited solely from drug treatment programs, a broad array of alternative determinants of HIV infection have been held constant, and the association has been examined with seroconversion data. The results lend support to the abiding concern about the risk of HIV infection among cocaine users.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1746528     DOI: 10.1093/oxfordjournals.aje.a116021

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  36 in total

1.  Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4+ and CD8+ T cells.

Authors:  P Di Francesco; R Falchetti; R Gaziano; G Lanzilli; I A Casalinuovo; G Ravagnan; E Garaci
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Reduced probability of HIV infection among crack cocaine--using injection drug users.

Authors:  M Y Iguchi; D A Bux
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

3.  Sociometric risk networks and risk for HIV infection.

Authors:  S R Friedman; A Neaigus; B Jose; R Curtis; M Goldstein; G Ildefonso; R B Rothenberg; D C Des Jarlais
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

4.  Sex-specific determinants of HIV infection among injection drug users in Montreal.

Authors:  J Bruneau; F Lamothe; J Soto; N Lachance; J Vincelette; A Vassal; E L Franco
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

Review 5.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 6.  Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Blaise Mathias-Costa; Vijeta Singh; Pankaj Seth; John Wang; Tsung-Ping Su
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

7.  Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users.

Authors:  Mariah M Marshall; Gregory D Kirk; Neil E Caporaso; Meredith C McCormack; Christian A Merlo; John C Hague; Shruti H Mehta; Eric A Engels
Journal:  Addict Behav       Date:  2010-09-26       Impact factor: 3.913

Review 8.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

9.  Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.

Authors:  D M Hartel; E E Schoenbaum
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.

Authors:  P De; E Roy; J-F Boivin; J Cox; C Morissette
Journal:  J Viral Hepat       Date:  2008-01-20       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.